382 related articles for article (PubMed ID: 12020864)
41. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
42. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
Dykstra LA; Schoenbaum GM; Yarbrough J; McNutt R; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):875-82. PubMed ID: 8246162
[TBL] [Abstract][Full Text] [Related]
43. 5HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus.
Pickard GE; Weber ET; Scott PA; Riberdy AF; Rea MA
J Neurosci; 1996 Dec; 16(24):8208-20. PubMed ID: 8987845
[TBL] [Abstract][Full Text] [Related]
44. Potentiation of the resetting effects of light on circadian rhythms of hamsters using serotonin and neuropeptide Y receptor antagonists.
Lall GS; Harrington ME
Neuroscience; 2006 Sep; 141(3):1545-52. PubMed ID: 16750888
[TBL] [Abstract][Full Text] [Related]
45. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
Huhman KL; Albers HE
Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
[TBL] [Abstract][Full Text] [Related]
46. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoids and hamster circadian activity rhythms.
Sanford AE; Castillo E; Gannon RL
Brain Res; 2008 Jul; 1222():141-8. PubMed ID: 18582849
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
Ito S; Mori T; Sawaguchi T
Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795
[TBL] [Abstract][Full Text] [Related]
49. Short-term constant light potentiation of large-magnitude circadian phase shifts induced by 8-OH-DPAT: effects on serotonin receptors and gene expression in the hamster suprachiasmatic nucleus.
Duncan MJ; Franklin KM; Davis VA; Grossman GH; Knoch ME; Glass JD
Eur J Neurosci; 2005 Nov; 22(9):2306-14. PubMed ID: 16262668
[TBL] [Abstract][Full Text] [Related]
50. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
[TBL] [Abstract][Full Text] [Related]
52. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
53. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
Kakinohana M; Nakamura S; Fuchigami T; Davison KJ; Marsala M; Sugahara K
Br J Anaesth; 2006 Jan; 96(1):88-94. PubMed ID: 16317029
[TBL] [Abstract][Full Text] [Related]
54. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.
Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P
Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622
[TBL] [Abstract][Full Text] [Related]
55. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
56. Potentiating action of MKC-242, a selective 5-HT1A receptor agonist, on the photic entrainment of the circadian activity rhythm in hamsters.
Moriya T; Yoshinobu Y; Ikeda M; Yokota S; Akiyama M; Shibata S
Br J Pharmacol; 1998 Nov; 125(6):1281-7. PubMed ID: 9863658
[TBL] [Abstract][Full Text] [Related]
57. The role of Period1 in non-photic resetting of the hamster circadian pacemaker in the suprachiasmatic nucleus.
Hamada T; Antle MC; Silver R
Neurosci Lett; 2004 May; 362(2):87-90. PubMed ID: 15193760
[TBL] [Abstract][Full Text] [Related]
58. Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster.
Weber ET; Gannon RL; Rea MA
J Biol Rhythms; 1998 Jun; 13(3):209-18. PubMed ID: 9615285
[TBL] [Abstract][Full Text] [Related]
59. GABA interacts with photic signaling in the suprachiasmatic nucleus to regulate circadian phase shifts.
Mintz EM; Jasnow AM; Gillespie CF; Huhman KL; Albers HE
Neuroscience; 2002; 109(4):773-8. PubMed ID: 11927159
[TBL] [Abstract][Full Text] [Related]
60. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
Kuzmin A; Sandin J; Terenius L; Ogren SO
J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
